Skip to main content
. 2019 Oct 8;18(6):6046–6056. doi: 10.3892/ol.2019.10970

Figure 1.

Figure 1.

CDK9 significantly shortens the survival of patients with colon cancer. (A) Association between CDK9 expression and the survival of patients with colon and rectal cancer. Kaplan-Meier plots were used to visualize the survival differences. Levels were divided into low and high levels (cut-off, 50%). P-values calculated using a log-rank test are shown in each plot. (B) CDK9 mRNA expression in different stages of colorectal cancer based on data btained from the GEPIA database. CDK9, cyclin-dependent kinase 9; COAD, colon adenocarcinoma; READ, rectum adenocarcinoma.